ADC3680

· Pulmagen Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADC3680, covering 2017-10-06 to 2017-10-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma [Phase 2]